TriSalus Life Sciences Reports on Shareholder Vote
Ticker: TLSIW · Form: 8-K · Filed: Jun 16, 2025 · CIK: 1826667
| Field | Detail |
|---|---|
| Company | Trisalus Life Sciences, Inc. (TLSIW) |
| Form Type | 8-K |
| Filed Date | Jun 16, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-vote, corporate-action, filing
TL;DR
TriSalus Life Sciences held a shareholder vote on June 12th, impacting common stock and warrants.
AI Summary
TriSalus Life Sciences, Inc. filed an 8-K on June 16, 2025, reporting on matters submitted to a vote of security holders on June 12, 2025. The filing pertains to common stock and warrants.
Why It Matters
This filing indicates that TriSalus Life Sciences held a vote of its security holders, which could lead to significant corporate actions or changes.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of a shareholder vote and does not immediately indicate financial distress or significant operational changes.
Key Numbers
- 001-39813 — SEC File Number (Identifies the company's filing history with the SEC.)
- 85-3009869 — EIN (Employer Identification Number for tax purposes.)
Key Players & Entities
- TriSalus Life Sciences, Inc. (company) — Registrant
- June 12, 2025 (date) — Date of earliest event reported
- June 16, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Westminster, Colorado (location) — Principal Executive Offices
FAQ
What specific matters were submitted to a vote of TriSalus Life Sciences' security holders on June 12, 2025?
The filing does not specify the exact proposals voted on, only that matters were submitted to a vote of security holders.
What is the significance of the common stock and warrants mentioned in the filing?
The filing notes that the report pertains to common stock and warrants, indicating these are likely the securities involved in the shareholder vote.
When was the report filed with the SEC?
The report was filed on June 16, 2025.
Where are TriSalus Life Sciences' principal executive offices located?
The principal executive offices are located at 6272 W 91st Ave, Westminster, Colorado 80031.
What was the former name of TriSalus Life Sciences, Inc.?
The former company name was MedTech Acquisition Corp, with a date of name change on September 30, 2020.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 16, 2025 regarding TriSalus Life Sciences, Inc. (TLSIW).